BRCA2 and inflammatory breast carcinoma: Variants in BRCA2 were found in much higher percentage of patients (≥20%) in three different datasets, including ours [18,24], when compared with the TCGA non-IBC cases (3.1%), thus suggesting HR deregulation in IBC.